Literature DB >> 12506162

The ups and downs of the estrogen receptor.

V Craig Jordan.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12506162     DOI： 10.1200/JCO.2003.10.008

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  3 in total

1.  Clinical instability of breast cancer markers is reflected in long-term in vitro estrogen deprivation studies.

Authors:  Jelena Milosevic; Johanna Klinge; Anna-Lena Borg; Theodoros Foukakis; Jonas Bergh; Nicholas P Tobin
Journal:  BMC Cancer       Date:  2013-10-11       Impact factor: 4.430

2.  Tamoxifen Action in ER-Negative Breast Cancer.

Authors:  Subrata Manna; Marina K Holz
Journal:  Sign Transduct Insights       Date:  2016-02-10

3.  Adiposity, hormone replacement therapy use and breast cancer risk by age and hormone receptor status: a large prospective cohort study.

Authors:  Rebecca Ritte; Annekatrin Lukanova; Franco Berrino; Laure Dossus; Anne Tjønneland; Anja Olsen; Thure Filskov Overvad; Kim Overvad; Françoise Clavel-Chapelon; Agnès Fournier; Guy Fagherazzi; Sabine Rohrmann; Birgit Teucher; Heiner Boeing; Krasimira Aleksandrova; Antonia Trichopoulou; Pagona Lagiou; Dimitrios Trichopoulos; Domenico Palli; Sabina Sieri; Salvatore Panico; Rosario Tumino; Paolo Vineis; José Ramón Quirós; Genevieve Buckland; Maria-José Sánchez; Pilar Amiano; María-Dolores Chirlaque; Eva Ardanaz; Malin Sund; Per Lenner; Bas Bueno-de-Mesquita; Carla H van Gils; Petra Hm Peeters; Sanda Krum-Hansen; Inger Torhild Gram; Eiliv Lund; Kay-Tee Khaw; Nick Wareham; Naomi E Allen; Timothy J Key; Isabelle Romieu; Sabina Rinaldi; Afshan Siddiq; David Cox; Elio Riboli; Rudolf Kaaks
Journal:  Breast Cancer Res       Date:  2012-05-14       Impact factor: 6.466
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.